Al Mondhiry H, Pierce WS, Pennock JL.Platelet release in coronary heart disease: Effect of antiplatelet drugs and coronary artery bypass graft. J Lab Clin Med1985;105: 397-397.
2.
Salvioni A, Marenzi G, Lauri G, et al.Beta-thromboglobulin plasma levels in the first week after myocardial infarction: Influence of thrombolytic therapy. Am Heart J1994;128: 472-472.
3.
Salvioni A, Perego GB, Marenzi G, et al.Platelet activity in the early stage of acute myocardial infarction: Relation to time of presentation, treatment with either tissue plasminogen activator or streptokinase and ciclooxygenase inhibition. J Thromb Thrombolysis1998;5: 65-65.
4.
Martinez-Sales V, Vila V, Reganon E, et al.Elevated thrombotic activity after myocardial infarction: A 2 year follow up study. Haemostasis1998;28: 301-301.
5.
Placanica G, Migliau G, Nasso G, et al.Short-term effect of exercise on platelet factor 4 in normal subjects and in patients with coronary artery disease. Cardiologia1999; 44: 993-993.
6.
Soeki T, Tamura Y, Fukuda N, Ito S.Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction. Jpn Circ J2000;64: 547-547.
7.
Caimi G, Hoffmann E, Montana M, et al.Haemorheological pattern in young adults with acute myocardial infarction. Clin Hemorheol Microcirc2003;29: 11-11.
8.
Caimi G, Hoffmann E, Canino B, et al.Polymorphonuclear leukocyte membrane fluidity and cytosolic Ca2+ content in young adults with acute myocardial infarction. Evaluation at the initial stage and after 12 months. Clin Hemorheol Microcirc2004;31: 41-41.
9.
Caimi G, Hoffmann E, Montana M, et al.Plasma markers of platelet and polymorphonuclear leukocyte activation in young adults with acute myocardial infarction. Clin Hemorheol Microcirc2005;32: 67-67.
